Jonathan Royds

Dr. Jonathan Royds


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 November 2014 in BMC Anesthesiology
Verified
Journal Article
Open access
PDF file
MCMark Campbell
Mark Campbell
HSHilary Shanahan
Hilary Shanahan
SASimon Ash
Simon Ash
JRJonathan Royds
Jonathan Royds
VHViera Husarova
Viera Husarova
CMConan McCaul
Conan McCaul
The cricothyroid membrane (CTM) is the recommended site of access to the airway during cricothyrotomy to provide emergency oxygenation. We sought to compare the ability of physicians to correctly identify the CTM in male and female patients. In a prospective observational study, anaesthetists were asked to locate the CTM by palpation which was then identified using ultrasound and the distance between the actual and estimated margin of the CTM was measured. Participants assessed the ease of CTM palpation using a visual analog scale. In a second series, the angulation of the posterior junction of the thyroid laminae was measured using ultrasound. 23 anaesthetists and 44 subjects participated. A total of 36 assessments were carried out in each gender. Incorrect identification of the CTM was more common in females (29/36 vs. 11/36, P < 0.001) and the distance from the CTM in the vertical plane was greater (11.0 [6.5–20.0] vs. 0.0 [0.0–10.0] mm, P < 0.001). In females distance from the CTM correlated positively with neck circumference (P = 0.005) and BMI (P = 0.00005) and negatively with subject height (P = 0.01). Posterior thyroid cartilage angulation was greater in females (118.6 ± 9.4° vs. 95.9 ± 12.9°, P = 0.02) and was lower in patients with correctly identified CTMs (100.0 ± 14.9° vs. 115.6 ± 15.9°, P = 0.02). VRS palpation correlated with decreased posterior thyroid cartilage angulation (P = 0.04). CTM localisation is more difficult in female subjects irrespective of body habitus. It may be prudent to localize this structure by additional means (e.g. ultrasound) in advance of any airway manoeuvres or to modify the cricothyrotomy technique in the event that it is necessary in an emergency.

26 August 2020 in Regional Anesthesia & Pain Medicine
Verified
Journal Article
Closed access
PDF file
AAAdnan Al-Kaisy
Adnan Al-Kaisy
JRJonathan Royds
Jonathan Royds
OAOmar Al-Kaisy
Omar Al-Kaisy
SPStefano Palmisani
Stefano Palmisani
DPDavid Pang
David Pang
SWStephen Ward
Stephen Ward
Introduction The publication of explant rates has established risk factors and a definitive objective outcome of failure for spinal cord stimulation (SCS) treating neuropathic pain. We present a UK study analyzing explants of electrical neuromodulation devices for different conditions over 11 years in a single center specializing in neuromodulation. Methods A retrospective analysis was performed using a departmental database between 2008 and 2019. Explants were analyzed according to condition, mode of stimulation and other demographics using logistic regression and Kaplan-Meier graphs with log-rank (Mantel-Cox) test. Results Out of a total of 1177 patients, the explant rate was 17.8% at 5 years and 25.2% at 10 years. Loss of efficacy was the most frequent reason for explant 119/181 (65%). Multivariant regression analysis indicated patients with back pain without prior surgery had a reduced risk of explant (p=0.03). Patients with SCS systems that had 10 kHz, options of multiple waveforms, and rechargeable batteries also had a decreased risk of explant (p<0.001). None of these findings were confirmed when comparing Kaplan-Meier graphs, however. Contrary to other studies, we found gender and age were not independent variables for explant. Conclusion These data contribute to a growing list of explant data in the scientific literature and give indications of what factors contribute to long-term utilization of electrical neuromodulation devices.

11 September 2012 in Colorectal Disease
Verified
Journal Article
Closed access
PDF file
JRJonathan Royds
Jonathan Royds
JOJ. M. O’rIordan
J. M. O’rIordan
EEE. Eguare
E. Eguare
DOD. O’rIordan
D. O’rIordan
PNP. C. Neary
P. C. Neary

1 January 2012 in International Journal of Surgery Case Reports
Verified
Journal Article
Open access
JRJonathan Royds
Jonathan Royds
SKS. Kieran
S. Kieran
CTC. Timon
C. Timon
INTRODUCTION: Surgicel (oxidized cellulose) is used for intra-operative haemostasis and adhesion prevention. Previously local tissue reactions to oxidized cellulose have been reported at many surgical sites, but not in the head and neck. PRESENTATION OF CASE: A 56 year old lady presented 30 days following total thyroidectomy with wound swelling and erythema. Multiple sinuses were noted within the wound, through which oxidized cellulose partially extruded. Following removal of the un-absorbed material the symptoms resolved over 3 days. DISCUSSION: The absence of any systemic symptoms confirm that this was most likely a type four hypersensitivity reaction. The removal of the unabsorbed material was a further unique part of this case. CONCLUSION: We present the first head and neck reaction to oxidized cellulose. This report serves to remind head and neck surgeons of the potential for local tissue reactions to this material.

12 August 2013 in British Journal of Surgery
Verified
Journal Article
Closed access
PDF file
JRJonathan Royds
Jonathan Royds
JOJ. M. O'Riordan
J. M. O'Riordan
EME. Mansour
E. Mansour
EEE. Eguare
E. Eguare
PNP. Neary
P. Neary

28 January 2020 in Trials
Verified
Journal Article
Open access
PDF file
AAAdnan Al-Kaisy
Adnan Al-Kaisy
JRJonathan Royds
Jonathan Royds
SPStefano Palmisani
Stefano Palmisani
DPDavid Pang
David Pang
SWSamuel Wesley
Samuel Wesley
JFJeremy Fairbank
Jeremy Fairbank
Introduction: Chronic neuropathic low back pain (CNLBP) is a debilitating condition in which established medical treatments seldom alleviate symptoms. Evidence demonstrates that high-frequency 10 kHz spinal cord stimulation (SCS) reduces pain and improves health-related quality of life in patients with failed back surgery syndrome (FBSS), but evidence of this effect is limited in individuals with CNLBP who have not had surgery. The aim of this multicentre randomised trial is to assess the clinical and cost-effectiveness of 10 kHz SCS for this population. Methods: This is a multicentre, double-blind, randomised, sham-controlled trial with a parallel economic evaluation. A total of 96 patients with CNLBP who have not had spinal surgery will be implanted with an epidural lead and a sham lead outside the epidural space without a screening trial. Patients will be randomised 1:1 to 10 kHz SCS plus usual care (intervention group) or to sham 10 kHz SCS plus usual care (control group) after receiving the full implant. The SCS devices will be programmed identically using a cathodal cascade. Participants will use their handheld programmer to alter the intensity of the stimulation as per routine practice. The primary outcome will be a 7-day daily pain diary. Secondary outcomes include the Oswestry Disability Index, complications, EQ-5D-5 L, and health and social care costs. Outcomes will be assessed at baseline (pre-randomisation) and at 1 month, 3 months and 6 months after device activation. The primary analyses will compare primary and secondary outcomes between groups at 6 months, while adjusting for baseline outcome scores. Incremental cost per quality-adjusted life year (QALY) will be calculated at 6 months and over the lifetime of the patient. Discussion: The outcomes of this trial will inform clinical practice and healthcare policy on the role of high-frequency 10 kHz SCS for use in patients with CNLBP who have not had surgery. Trial registration: Clinicaltrials.gov, NCT03470766. Registered on 20 March 2018. Disclaimer: The views expressed here are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. The NIHR had no role in the study design, writing of the manuscript or the decision to submit for publication. Roles and Responsibilities: AK, SP, DP, SW, RST, AC, SE, LM, RD and JF all contributed to the trial design and to securing trial funding. AK, JR, SP, DP, and SE are involved in the recruitment, the intervention and the follow-up. SW will perform data collection and analysis. RST will be responsible for the statistical analysis, and RD will be responsible for the health economic analysis. All authors read and approved the final manuscript.